Effects of co-administration of cisplatin with imidazolium hexafluorocuprate of α-tocopherol on cisplatin induced toxicity and antitumor activity

Toxicology International

Volumn 14, Issue 1, 2007, Pages 83-87

  Sarna, Suniti ^a   Bhola, Rakesh K ^a  

^a GAUHATI UNIVERSITY   (India)

Author keywords

tocopherol; Cisplatin; Copper II Complex; Dalton's lymphoma; Imidazolium hexafluorocuprate

Indexed keywords

ALPHA TOCOPHEROL; CISPLATIN; HEMOGLOBIN; IMIDAZOLE DERIVATIVE; IMIDAZOLIUM HEXAFLUOROCUPRATE; NITROGEN; SODIUM CHLORIDE; UNCLASSIFIED DRUG; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD TOXICITY; CANCER INHIBITION; CANCER SIZE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DALTON LYMPHOMA; DRUG DOSE COMPARISON; DRUG INDUCED DISEASE; DRUG POTENTIATION; FEMALE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; LEUKOCYTE COUNT; LYMPHOMA; MALE; MONOTHERAPY; MOUSE; NONHUMAN; PROTECTION; SINGLE DRUG DOSE; UREA NITROGEN BLOOD LEVEL; WEIGHT GAIN;

MUS;

EID: 34547965813     PISSN: 09716580     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Bodenner, DL, Dedon PC, Keng, PC and Keng PC (1986): Selective protection against cis-diammine dichloroplatinum (II) induced toxicity in kidney, gut and bone marrow by diethyldithiocarbamate. Cancer Res., 46, 2751-2756.
2. Carter, SK (1984): Cisplatin - Past, present and future, in: Coordination Complexes in Cancer Chemotherpy (Eds. MP Hacker, ER Douple and IH Krakoff) pp. 359-376, Martinus Nijhpff Publishing, Boston.
3. Chu, G (1994): Cellular responses to cisplatin. J. Biol. Chem., 269, 787-790.
4. Dabholkar, M and Reed E (1996): Cisplatin, in: Cancer Chemotherapy and Biological Response Modifiers (Eds: HMPinedo, DL Longo and BA Chabner) pp. 88-110; Elsevier Science Publishers, Netherlands
5. Jurga, L, Misurova, E, Kovac, V and Seveikova I (1994): The role of cisplatin in chemotherapy of advanced breast cancer. Neoplasma, 14, 347-352.
6. Krakoff, IH (1979): Nephrotoxicity of cis-dichlorodiammine platinum. Cancer Treat. Rep. 63, 1523-1525.
7. Kramer, RA (1989): Protection against cisplatin nephrotoxicity by prochlorperazine. Cancer Chemother. Pharmacol., 25, 156-160..
8. Naganuma, A, Satoh, M and Imura, N (1987): Prevention of lethal and renal toxicity of cis-diammine dichloroplatinum (II) by induction of metallothionein synthesis without compromising its antitumor activity in mice. Cancer Res, 47, 983-987.
9. Okhawa, K, Tsukada, Y and Dohzono, H. (1988): The effects of co-administration of selenium and cisplatin (CDDP) on CDDP-induced toxicity and antitumor activity. Br. J. Cancer, 58, 38-41.
10. Pil, P and Lippard, SJ. (1997): Cisplatin and related drugs, In: Encyclopedia of cancer (Ed: JRBertino) pp. 392-410; Academic Press, Inc. San Diego.
11. Prasad, KN and Rama, BN (1984): Modification of the effect of pharmacological agents, ionizing radiation and hyperthermia on tumor cells by vitamin A, in: Vitamins, nutrition and cancer (Ed. KN Prasad); pp. 76-104, Basel, Karger.
12. Prasad, SB and Giri, A (1994): Antitumor effect of cisplatin against murine ascites Dalton's lymphoma. Ind. J. Exp. Biol., 32, 155-162.
13. Rosenberg, B (1985): Fundamental studies with cisplatin. Cancer 55, 2303-2316.
14. Sarna, S, Kumar, A and Bhola, RK (1996): Combined effect of cisplatin and α-tocopherol on mice bearing Dalton's lymphoma. Current Science, 70, 1022-1024.
15. Sarna, S and Bhola, RK (2006): Antitumor effect of imidazolium hexafluorocuprate and cisplatin against Dalton's lymphoma in mice. J. Exptl. Zool. India, 9, 189-195.
16. Shimada, H, Sugimachi, N and Funakoshi, T (1993): Prevention of renal toxicity of cis-diamminedichloro platinum by dithiocarbamates in rats. Toxicology letters, 66, 193-198.
17. Sodhi, A and Aggarwal, SK. (1974): Effects of cis-dichlorodiammine platinum (II) in the regression of Sarcoma-180: A fine structural study. J. Natl. Cancer Inst., 53, 85-101.
18. Sue, K, Nakagawara, A. and Okuzono, S (1988): Combined effects of vitamin E (Alpha-tocopherol) and cisplatin on the growth of murine neuroblastoma in vivo. Eur. J. Cancer Clin. Oncol., 24, 1751-1758